Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


UCL - Producing the UK's brightest self-employed graduates

31 October 2011

UCL

UCL has many claims to be one of the UK's leading universities for entrepreneurship. It has the highest proportion of self-employed graduates in the UK, offers arguably the widest range of support services for graduates starting businesses and is part of the University of London, which has produced more millionaires than any other UK institution.

For those that chose to pursue more conventional business routes, the value of the skills still appears to hold. In a recent survey of global business leaders preferences for recruitment UCL was placed twelfth in the world.